7701. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.
作者: Benjamin P Linas.;Devra M Barter.;Jake R Morgan.;Mai T Pho.;Jared A Leff.;Bruce R Schackman.;C Robert Horsburgh.;Sabrina A Assoumou.;Joshua A Salomon.;Milton C Weinstein.;Kenneth A Freedberg.;Arthur Y Kim.
来源: Ann Intern Med. 2015年162卷9期619-29页
Chronic infection with hepatitis C virus (HCV) genotype 2 or 3 can be treated with sofosbuvir without interferon. Because sofosbuvir is costly, its benefits should be compared with the additional resources used.
7702. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force.
作者: Amy G Cantor.;Christina Bougatsos.;Tracy Dana.;Ian Blazina.;Marian McDonagh.
来源: Ann Intern Med. 2015年162卷8期566-76页
Routine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic pregnant women could improve maternal and infant health outcomes.
7705. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for thyroid disease.
|